Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi: intercure.co (INCR)

InterCure Ltd. is expanding its pharmacy presence through global partnerships, maintaining high margins via premium brands despite regulatory pressure. Tracking EBITDA fluctuations on GURU.Markets, we note that the 0.00 mark reflects the current state of operating profit. The company's revenues are based on the sale of medical and recreational cannabis products through specialized centers.

INCR Bathi operasional EBITDA intercure.co (23.11.2025 - 11.11.2026)

InterCure - rincian analitis lan metrik utama (INCR)

- rega pasar lan target rega analis:

Rega saham InterCure Ltd|INCR - Bagan rega target

- indikator kapitalisasi bursa perusahaan:

Nilai pasar InterCure|INCR - Nilai Total Perusahaan

- informasi kapitalisasi buku:

Nilai Akuntansi saben Saham InterCure|INCR - Kapitalisasi Buku|Kapitalisasi Pasar marang Nilai Buku intercure.co|INCR - Aset Agregat Perusahaan

- data tingkat utang lan likuiditas finansial:

Rasio Utang marang Ekuitas InterCure Ltd.|INCR - Rasio utang jangka dawa marang ekuitas|Rasio silihan jangka cendhak marang modal InterCure Ltd|INCR - Gunggung utang perusahaan|Utang-utang marang nilai buku InterCure|INCR - Utang jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan InterCure|Indikator likuiditas cepet intercure.co

- data bathi lan kelipatan valuasi:

INCR - Penghasilan resik|Proyeksi bathi mangsa ngarep InterCure Ltd.|INCR - Rasio rega marang bathi|Pangali mangsa ngarep rega marang bathi InterCure Ltd|INCR - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan InterCure|INCR - Bathi operasional sadurunge ngurangi amortisasi|Bathi saben saham sajroning taun lumaku InterCure|INCR - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan intercure.co|INCR - Wutah bathi resik saben saham ing taun iki|Proyeksi tambahing bathi saben saham ing taun ngarep InterCure Ltd.

Ringkesan analitik perusahaan:InterCure Ltd.

This indicator reflects the actual cash balance from core operations before depreciation and taxes, demonstrating the objective efficiency of business processes. Analysis of the EBITDA chart allows for an assessment of how successfully InterCure Ltd. (INCR) monetizes vertical integration while maintaining moderate dependence on external logistics partners and foreign medical cannabis distributors.

Pesaing InterCure Ltd. (INCR)